Granulomatosis With Polyangiitis Clinical Trials 2023
Browse 10 Granulomatosis With Polyangiitis Medical Studies Across 21 Cities
4 Phase 3 Trial · 39 Granulomatosis With Polyangiitis Clinics
Reviewed by Michael Gill, B. Sc.
10 Granulomatosis With Polyangiitis Clinical Trials Near Me
Top Hospitals for Granulomatosis With Polyangiitis Clinical Trials
University of Pennsylvania
Philadelphia
4Active Trials
15All Time Trials for Granulomatosis With Polyangiitis
2006First Granulomatosis With Polyangiitis Trial
Mayo Clinic Rochester
Rochester
2Active Trials
2All Time Trials for Granulomatosis With Polyangiitis
2015First Granulomatosis With Polyangiitis Trial
Mayo Clinic
Rochester
2Active Trials
11All Time Trials for Granulomatosis With Polyangiitis
2000First Granulomatosis With Polyangiitis Trial
National Jewish Health
Denver
2Active Trials
2All Time Trials for Granulomatosis With Polyangiitis
2006First Granulomatosis With Polyangiitis Trial
Top Cities for Granulomatosis With Polyangiitis Clinical Trials
Granulomatosis With Polyangiitis Clinical Trials by Phase of TrialN/A Granulomatosis With Polyangiitis Clinical Trials
Granulomatosis With Polyangiitis Clinical Trials by Age Group1Active Granulomatosis With Polyangiitis Clinical Trials
1Number of Unique Treatments
0Number of Active Locations
< 65 Granulomatosis With Polyangiitis Clinical Trials
Most Recent Granulomatosis With Polyangiitis Clinical Trials1Active Granulomatosis With Polyangiitis Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Treatment Name
Active Granulomatosis With Polyangiitis Clinical Trials
All Time Trials for Granulomatosis With Polyangiitis
First Recorded Granulomatosis With Polyangiitis Trial
Open-Label
2
2
2017
Obinutuzumab
1
1
2023
Depemokimab
1
1
2022
Trimethoprim Sulfamethoxazole
1
1
2019
Naltrexone Hydrochloride
1
1
2019
About The Author
Michael Gill - B. Sc.
First Published: October 29th, 2021
Last Reviewed: August 15th, 2023
References1 Lee Y, Hojjati M. Benralizumab as a Potential Adjunctive Therapy in Eosinophilic Granulomatosis With Polyangiitis. J Clin Rheumatol. 2021 Dec 1;27(8S):S401-S402. doi: 10.1097/RHU.0000000000001419. No abstract available. https://pubmed.ncbi.nlm.nih.gov/324532172 Manka LA, Guntur VP, Denson JL, Dunn RM, Dollin YT, Strand MJ, Wechsler ME. Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis. Ann Allergy Asthma Immunol. 2021 Jun;126(6):696-701.e1. doi: 10.1016/j.anai.2021.01.035. Epub 2021 Feb 4. https://pubmed.ncbi.nlm.nih.gov/335484683 Lee Y, Hojjati M. Benralizumab as a Potential Adjunctive Therapy in Eosinophilic Granulomatosis With Polyangiitis. J Clin Rheumatol. 2021 Dec 1;27(8S):S401-S402. doi: 10.1097/RHU.0000000000001419. https://pubmed.ncbi.nlm.nih.gov/324532174 Hung W, Cusnir I, Habib S, Smylie M, Solez K, Yacyshyn E. Immune checkpoint inhibitor-induced granulomatosis with polyangiitis. Rheumatology (Oxford). 2021 Jun 18;60(6):e190-e191. doi: 10.1093/rheumatology/keaa818. https://pubmed.ncbi.nlm.nih.gov/333678375 Hung W, Cusnir I, Habib S, Smylie M, Solez K, Yacyshyn E. Immune checkpoint inhibitor-induced granulomatosis with polyangiitis. Rheumatology (Oxford). 2021 Jun 18;60(6):e190-e191. doi: 10.1093/rheumatology/keaa818. No abstract available. https://pubmed.ncbi.nlm.nih.gov/333678376 Krischer J, Cronholm PF, Burroughs C, McAlear CA, Borchin R, Easley E, Davis T, Kullman J, Carette S, Khalidi N, Koening C, Langford CA, Monach P, Moreland L, Pagnoux C, Specks U, Sreih AG, Ytterberg S, Merkel PA; Vasculitis Clinical Research Consortium. Experience With Direct-to-Patient Recruitment for Enrollment Into a Clinical Trial in a Rare Disease: A Web-Based Study. J Med Internet Res. 2017 Feb 28;19(2):e50. doi: 10.2196/jmir.6798. https://pubmed.ncbi.nlm.nih.gov/28246067